Like I said before
1)Ath has to get a biotech name for their drug from the WHO
2) Drug manufacture in the US
3) FDA … accelerated approval..
4)Partner … a) Distribution
. b) continuation Phase 3
All takes time….
I see no problems now that we have approx $51 million in the BANk..
With a MC over $100 million
- Forums
- ASX - By Stock
- Greatest risk of AD is poor control of ferroptosis
ATH
alterity therapeutics limited
Add to My Watchlist
0.00%
!
1.1¢

Like I said before1)Ath has to get a biotech name for their drug...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.4M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.0¢ | $16.80K | 1.551M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 11582464 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 2387682 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
32 | 11582464 | 0.010 |
26 | 26394228 | 0.009 |
14 | 28040963 | 0.008 |
12 | 4058106 | 0.007 |
14 | 8953518 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 2387682 | 8 |
0.012 | 21924784 | 29 |
0.013 | 8080040 | 15 |
0.014 | 12788180 | 6 |
0.015 | 2059976 | 9 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
CDE
CODEIFAI LIMITED
John Houston / Martin Ross, Executive Chairman / COO
John Houston / Martin Ross
Executive Chairman / COO
Previous Video
Next Video
SPONSORED BY The Market Online